HLS is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
|Absorica||Acne||U.S.||Acquired 2016||Marketed by a third party|
|Vascepa||CV risk reduction||Canada||Approved 2019||Marketed|
|CSAN Pronto||WBC Point-of-Care Diagnostic||Canada||Approved 2019||Marketed|
|Trinomia||CV risk reduction||Canada||In-licensed 2017||Submission under review|
|Perseris||Schizophrenia||Canada||In-licensed 2019||Submission under review|
For U.S. Residents, click here for commercial product information.
For Canadian Residents, please click on the Canadian flag above for more commercial product information.
Brand names you know. Safe and effective results you trust.